In a curcumin formulation subgroup analysis, the effects on AST, ALT, and the resolution of hepatic steatosis remained significant in patients receiving bioavailability-enhanced forms, suggesting this curcumin supplement formulation may be more efficacious than crude extracts or turmeric powder. The gene discussed is GPT; the disease is Hepatic steatosis.